Cyblex MV 80.2 Tablet

Introduction

Cyblex MV is a prescription medication that combines three active ingredients: Voglibose, Metformin, and Gliclazide. It is commonly used to manage blood sugar levels in patients with type 2 diabetes mellitus.

Uses

Cyblex MV is prescribed to individuals with type 2 diabetes mellitus to help control their blood sugar levels. It is used as an adjunct to diet and exercise to improve glycemic control.

Dosage and Administration

The dosage of Cyblex MV may vary depending on individual patient factors, such as their blood sugar levels and response to treatment. Follow the instructions provided by your healthcare provider or the directions on the prescription label.

Generally, the recommended starting dose for Cyblex MV is one tablet taken orally with meals, usually once or twice daily. Your healthcare provider may adjust the dosage based on your blood sugar levels and response to treatment. Take Cyblex MV regularly to achieve the best results.

Mechanism of Action

Cyblex MV combines three active ingredients, each with its own mechanism of action.

• Voglibose: It belongs to a class of medications called alpha-glucosidase inhibitors. Voglibose works by slowing down the absorption of carbohydrates in the small intestine, thereby reducing the increase in blood sugar levels after meals.
• Metformin: It belongs to a class of medications called biguanides. Metformin works by reducing the production of glucose in the liver and improving the body’s sensitivity to insulin, which helps lower blood sugar levels.
• Gliclazide: It belongs to a class of medications called sulfonylureas. Gliclazide works by stimulating the pancreas to release more insulin, which helps lower blood sugar levels.

By combining these three active ingredients, Cyblex MV helps improve glycemic control in patients with type 2 diabetes mellitus.

Side Effects

Common side effects may include:

• Nausea
• Diarrhea
• Abdominal discomfort
• Headache
• Hypoglycemia (low blood sugar)

Serious side effects are rare but may include:

• Allergic reactions
• Severe hypoglycemia
• Lactic acidosis (rare but serious condition)

If you experience any severe or persistent side effects, seek medical attention immediately. If you experience symptoms of hypoglycemia, such as dizziness, confusion, or sweating, you should consume a source of glucose (such as fruit juice or candy) and seek medical assistance promptly.

Drug Interactions

Cyblex MV may interact with other medications, including prescription drugs, over-the-counter medications, and herbal supplements. Some common drug interactions may include:

• Certain antibiotics (e.g., ciprofloxacin)
• Beta-blockers (e.g., propranolol)
• Diuretics (e.g., furosemide)
• Nonsteroidal anti-inflammatory drugs (e.g., ibuprofen)
• Certain anticoagulants (e.g., warfarin)

inform your healthcare provider about all the medications and supplements you are currently taking to avoid potential drug interactions.

Precautions

Before taking Cyblex MV, inform your healthcare provider about any medical conditions you have, especially:

• Kidney or liver disease
• Heart disease
• Allergies to any medications or substances

Cyblex MV may not be suitable for everyone. It is contraindicated in individuals with:

• Severe renal impairment
• Severe hepatic impairment
• Diabetic ketoacidosis
• Type 1 diabetes mellitus

Additionally, avoid alcohol consumption while taking Cyblex MV, as it may increase the risk of lactic acidosis.

Storage

Cyblex MV should be stored at room temperature, away from moisture and heat. Keep the medication out of the reach of children and pets. Do not use Cyblex MV if it has expired or if the packaging is damaged.

Patient Tips

Here are some additional tips for patients using Cyblex MV:

• Follow your healthcare provider’s instructions regarding diet and exercise while taking this medication.
• Monitor your blood sugar levels regularly and report any significant changes to your healthcare provider.
• Be aware of the signs and symptoms of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) and take appropriate action as advised by your healthcare provider.
• Carry a source of glucose (such as glucose tablets or candy) with you in case of hypoglycemia.
• Attend regular check-ups with your healthcare provider to monitor your response to treatment and address any concerns or questions you may have.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Gliclazide: a medicine to treat type 2 diabetes (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Dacadis MR 30mg Modified Release Tablets (Health Professionals SmPC) Available at:
• Gliclazide (International database) (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• metformin (RX) [Accessed 21 Jun. 2024] (online) Available at:
• Oral hypoglycemics overdose (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Tomlinson B, Li YH, Chan P. Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2022 Dec;23(17):1869-1877. doi: 10.1080/14656566.2022.2141108. Epub 2022 Nov 10. [Accessed 21 Jun. 2024] Available at: